跳至主要内容
临床试验/NCT02034240
NCT02034240已完成不适用

Secretion of Neutrophil Gelatinase Associated Lipocalin in Septic Patients and the Development of Acute Kidney Injury

Sygehus Lillebaelt1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
1
主要终点
Development of Acute Kidney Failure

研究概览

简要总结

Patients with severe infection and sepsis are in high risk of hypo perfusion and therefore organ affection. Temporary or permanent kidney failure is a common complication in these patients. Today's golden standard for kidney failure detection is creatinine levels rising and / or oliguria. The investigators hypothesize that an even more sensitive biomarker; neutrophil gelatinase associated lipocalin(NGAL) in urine can predict kidney injury before creatinine levels rise. In recent studies NGAL in urine seem to be a sensitive biomarker in these patient to predict kidney injury, but the time factor for sampling optimally is not known. In this pilot study the investigators sample the urine at admission within the first hour of hospitalization to investigate if NGAL can be used as a predictor in an emergency setting.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe sepsis
  • Septic shock
  • Patients must not be able to give consent

排除标准

  • Underaged (18 years )
  • known kidney injury
  • Fully alert patients that can give consent

结局指标

主要结局

Development of Acute Kidney Failure

时间窗: During hospitalization, anticipated approximately 5 weeks

次要结局

  • Levels of NGAL in patients with kidney failure compared to creatinine(During hospitalization, anticipated approximately 5 weeks)

研究者

发起方
Sygehus Lillebaelt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Claes Falkenberg Elvander

Medical Doctor

Sygehus Lillebaelt

研究点 (1)

Loading locations...

相似试验